Weill Cornell Bone Marrow Transplant Program

The Bone Marrow and Hematopoietic Stem Cell Transplant Program

The Bone Marrow and Hematopoietic Stem Cell Transplantation Program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is an internationally known center of excellence, providing a comprehensive, multidisciplinary approach for patients with cancer and blood diseases in need of stem cell transplant.

Patients come to our transplant program from the tri-state region, across the nation, and around the globe. The transplant program averages 170 stem cell transplants a year utilizing state-of-the-art technologies to provide the best, most comprehensive care available.

Our program is one of the nation’s leading centers in stem cell transplantation, including:

Autologous transplant
Transplant utilizing the patient’s own stem cells. Usually for patients with lymphoma, multiple myeloma, or auto-immune disorders followed by rescue with the patient’s own stem cells.

Matched allogeneic transplant
Transplant of stem cells from a related or unrelated donor with a similar HLA type. The treatment of choice for many patients with blood disorders, lymphoma or myeloma.

Haploidentical + cord blood (Haplo-cord) transplant
A transplant utilizing 2 graft sources- A related (or unrelated donor) with a different HLA type, combined with an umbilical cord blood unit. For patients who lack an HLA identical donor, and are in need of a transplant. A novel procedure combining umbilical cord blood with cells from a family donor has excellent outcomes.

Umbilical cord allogeneic transplant
Transplant of stem cells from an umbilical cord blood unit from an unrelated donor.

Syngeneic transplant
Transplant of stem cells from an identical twin donor.